Finally! Disclosure regarding the new UFO ETF.

In February 2025, Tuttle Capital Management filed with the U.S. Securities and Exchange Commission (SEC) to introduce the Tuttle Capital UFO Disclosure AI Powered ETF (ticker: UFOD). This innovative exchange-traded fund (ETF) aims to invest in companies potentially involved in advanced or "reverse-engineered" alien technologies, spurred by recent disclosures about unidentified flying objects (UFOs). 

Investment Focus

The UFOD ETF plans to allocate at least 80% of its net assets to aerospace and defense firms that may be engaged in classified research and development projects related to advanced technologies. This includes companies rumored to work with technologies that could lead to groundbreaking advancements. Additionally, the fund intends to take short positions against firms that could be negatively impacted by potential breakthroughs in these technologies. ​

Speculative Nature

Matthew Tuttle, CEO of Tuttle Capital, acknowledges the speculative nature of this investment approach. He notes that while government confirmation of advanced alien technologies remains uncertain, the potential financial gains from such discoveries could be substantial. The fund's strategy is contingent upon credible information from government disclosures regarding UFO-related research. 

Market Context

The launch of UFOD comes at a time when interest in space-related investments is growing. For instance, the Procure Space ETF (ticker: UFO), which focuses on companies engaged in space-related businesses, recently hit a 52-week high, moving up 74.2% from its 52-week low. This reflects a broader investor appetite for exposure to the burgeoning space economy.​

Conclusion

The Tuttle Capital UFO Disclosure AI Powered ETF represents a bold and speculative approach to investing in potential technological advancements linked to UFOs. While the fund's success depends on uncertain government disclosures and the realization of rumored technologies, it highlights the evolving landscape of thematic ETFs catering to investor interest in unconventional sectors.